Clinicopathological significance and prognostic value of CD133 expression in triple‐negative breast carcinoma (Q54616742)

1 June 2018

reason for preferred rank

title

Clinicopathological significance and prognostic value of CD133 expression in triple‐negative breast carcinoma (English)

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2011.01894.X

23 November 2024

Clinicopathological significance and prognostic value of CD133 expression in triple-negative breast carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21276138

23 November 2024

Po Zhao

1 reference

1 June 2018

Yali Lu

series ordinal

1 reference

1 June 2018

Xuege Jiang

series ordinal

1 reference

1 June 2018

Xiaoying Li

series ordinal

1 reference

1 June 2018

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21276138

23 November 2024

publication date

28 February 2011

1 reference

1 June 2018

full work available at URL

https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1349-7006.2011.01894.x

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21276138

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1349-7006.2011.01894.x

23 November 2024

1 reference

DOI

https://api.crossref.org/works/10.1111/J.1349-7006.2011.01894.X

https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1349-7006.2011.01894.x

23 November 2024

1 reference

DOI

https://api.crossref.org/works/10.1111/J.1349-7006.2011.01894.X

23 November 2024

1 reference

1 June 2018

volume

102

1 reference

1 June 2018

issue

1 reference

1 June 2018

page(s)

1107-1111

1 reference

1 June 2018

Molecular portraits of human breast tumours

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01894.X

Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01894.X

High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01894.X

Repeated observation of breast tumor subtypes in independent gene expression data sets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01894.X

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01894.X

Steroid hormone receptor status of mouse mammary stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01894.X

CD133 positive endothelial progenitor cells contribute to the tumour vasculature in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01894.X

Identification of human brain tumour initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01894.X

CD133, one of the markers of cancer stem cells in Hep-2 cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01894.X

Prospective identification of tumorigenic breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01894.X

A human colon cancer cell capable of initiating tumour growth in immunodeficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01894.X

Identification and expansion of human colon-cancer-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01894.X

Organotypic distribution of stem cell markers in formalin-fixed brain harboring glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01894.X

Intratumoral Expression Level of Epidermal Growth Factor Receptor and Cytokeratin 5/6 Is Significantly Associated With Nodal and Distant Metastases in Patients With Basal-like Triple-Negative Breast Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01894.X

14-3-3sigma expression is an independent prognostic parameter for poor survival in colorectal carcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01894.X

Expression of the "stem cell marker" CD133 in pancreas and pancreatic ductal adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01894.X

Expression and clinical significance of stem cell marker CD133 in human neuroblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01894.X

Impact of American Society of Clinical Oncology/College of American Pathologists guideline recommendations on HER2 interpretation in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01894.X

Determination of HER2 amplification by in situ hybridization: when should chromosome 17 also be determined?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2011.01894.X

23 November 2024

Identifiers

DOI

1 reference

1 June 2018

1 reference

1 June 2018